Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Pacira BioSciences, Inc.
organization3 mentionslast seen Nov 5, 2026
Leader in innovative non-opioid pain therapies being acquired by Viatris.
Relationships 10
- Pacira BioSciences, Inc.employsFrank D. Lee99% confidence2 sources
- Viatris Inc.acquiresPacira BioSciences, Inc.99% confidence2 sources
- Pacira BioSciences, Inc.commercializesEXPAREL99% confidence2 sources
- Pacira BioSciences, Inc.commercializesZILRETTA99% confidence2 sources
- Pacira BioSciences, Inc.developsPCRX-20199% confidence2 sources
- Pacira BioSciences, Inc.employsKristen Williams97% confidence1 source
- Viatris Inc.acquiresPacira BioSciences, Inc.95% confidence1 source
- Pacira BioSciences, Inc.developsEXPAREL95% confidence1 source
- Pacira BioSciences, Inc.developsZILRETTA95% confidence1 source
- Pacira BioSciences, Inc.applies tonon-opioid pain management85% confidence1 source
Relationship
Pacira BioSciences, Inc.commercializesZILRETTA
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGAROct 8, 2026Pacira BioSciences, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 7.01: Regulation FD Disclosure; Item 9.01: Financial Statements and Exhibits
Pacira has two commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic for post-surgical pain management and ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
- filingSEC EDGAROct 8, 2026Viatris Inc 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Pacira has two commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic for post-surgical pain management and ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)